Magangcong, Asnia P.
HRN: 27-44-83 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
CEFTRIAXONE 1G (VIAL)
12/27/2025
01/02/2026
IV
2g
OD
UTI
Checking Initial Appropriateness
01/03/2026
CEFUROXIME 500MG (TAB)
01/03/2026
01/09/2026
ORAL
500mg
BID
UTI
Checking Final Appropriateness
01/08/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/08/2026
01/15/2026
IV
4.5g
Q8
UTI, IV Site Phlebitis, (DM Pt)
Checking Initial Appropriateness